MR
Mohammed Rafeek
About Mohammed Rafeek
Data last updated:
Mohammed Rafeek is a Managing Director at Septalyte Bio Pharma Private Limited (since 2023). Septalyte Bio Pharma Private Limited reported revenue of ₹31,536 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Septalyte Bio Pharma Private Limited U46497KL2023PTC082693 | Managing Director | 28 Jul 2023 | 2023 | ₹31,536 (FY 2024) | Active |
Board colleagues of Mohammed Rafeek
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shiju Karthikeyan Vasanthakumari | 10258309 | Septalyte Bio Pharma Private Limited | Director |
| Vishnu Narayanan Madhavan Pillai | 10258308 | Septalyte Bio Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Rafeek
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Rafeek
Mohammed Rafeek currently holds 1 directorship: Septalyte Bio Pharma Private Limited (Managing Director, since 28 Jul 2023, revenue ₹31,536 (FY 2024)).
Mohammed Rafeek was first appointed on 28 Jul 2023 as Managing Director at Septalyte Bio Pharma Private Limited.
The current boards of Mohammed Rafeek's companies include Shiju Karthikeyan Vasanthakumari (Septalyte Bio Pharma Private Limited), Vishnu Narayanan Madhavan Pillai (Septalyte Bio Pharma Private Limited).